CINECA IRIS Institutional Research Information System

GIRAUDO, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.521
EU - Europa 3.424
AS - Asia 2.275
AF - Africa 65
OC - Oceania 28
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 11
Totale 10.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.440
CN - Cina 1.276
IT - Italia 1.098
DE - Germania 327
IE - Irlanda 318
SG - Singapore 283
FR - Francia 276
SE - Svezia 271
GB - Regno Unito 227
UA - Ucraina 177
FI - Finlandia 165
JP - Giappone 147
AT - Austria 121
KR - Corea 120
DK - Danimarca 102
PL - Polonia 85
VN - Vietnam 80
CA - Canada 73
IN - India 71
HK - Hong Kong 69
BE - Belgio 51
ID - Indonesia 44
NL - Olanda 44
SN - Senegal 44
TW - Taiwan 41
ES - Italia 38
CH - Svizzera 34
IL - Israele 33
AU - Australia 25
TR - Turchia 24
IR - Iran 23
RU - Federazione Russa 19
BR - Brasile 14
RO - Romania 14
TH - Thailandia 14
HU - Ungheria 12
PK - Pakistan 12
GR - Grecia 11
ZA - Sudafrica 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
MX - Messico 7
SA - Arabia Saudita 7
AR - Argentina 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
CO - Colombia 4
HR - Croazia 4
LT - Lituania 4
NO - Norvegia 4
AM - Armenia 3
CI - Costa d'Avorio 3
CL - Cile 3
EG - Egitto 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
DZ - Algeria 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
RS - Serbia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 10.351
Salva come PNG Salva come JPEG
Città #
Chandler 501
Beijing 384
Ann Arbor 359
Dublin 315
Torino 295
Fairfield 259
Houston 223
Singapore 197
Ashburn 174
Woodbridge 151
Dearborn 147
Jacksonville 146
Seattle 137
Wilmington 135
Villeurbanne 129
Vienna 117
Nyköping 113
Shanghai 108
Redwood City 103
Cambridge 102
Guangzhou 98
Princeton 95
Medford 91
Columbus 88
Milan 84
Pisa 81
Hangzhou 62
Warsaw 62
Nanjing 61
Fremont 55
Turin 50
Dong Ket 46
Boston 44
Jakarta 43
Tokyo 40
Wuhan 36
Brussels 34
Rome 33
Los Angeles 29
Taipei 29
Boardman 27
San Diego 27
Jinan 26
Helsinki 23
London 23
Hefei 22
Changsha 20
Chengdu 20
New York 20
Frankfurt am Main 18
San Francisco 18
Central 17
Xian 17
Norwalk 16
Paris 16
Menlo Park 15
Munich 15
Ottawa 15
Phoenix 15
Chongqing 14
Falls Church 14
Santa Clara 14
Dallas 13
Tianjin 13
Viterbo 13
Zhengzhou 13
Central District 12
Fuzhou 12
Hebei 12
Silver Spring 12
Toronto 12
Verona 12
Herzliya 11
Kunming 11
Chicago 10
New Haven 10
Bethesda 9
Istanbul 9
Leiden 9
Luni 9
Nanchang 9
Philadelphia 9
Simi Valley 9
Trieste 9
Barcelona 8
Birmingham 8
Cincinnati 8
Duncan 8
Hong Kong 8
Lanzhou 8
Pittsburgh 8
Rehovot 8
Sassari 8
Shenzhen 8
Zurich 8
Amsterdam 7
Bari 7
Créteil 7
Durban 7
Florence 7
Totale 6.029
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.868
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 640
PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM 286
Semaphorins in cardiovascular medicine. 285
Regulation of HMGCoA reductase Activity by Policosanol and Octacosadienol, a New synthetic Analogue of Octacosanol 271
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 243
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling 222
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. 199
NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE 194
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. 193
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 192
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 186
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 169
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 158
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 156
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation 154
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 152
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers 148
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. 143
The role of semaphorins and their receptors in vascular development and cancer 134
Class 3 semaphorins in cardiovascular development 133
Effect of inhibiting the sterol biosynthesis pathway and the cholesterol content in the regulation of angiogenesis in vitro and in vivo 118
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth 114
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 111
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 110
Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. 108
Biological aspects of tumour angiogenesis 107
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 103
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 101
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 97
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety 94
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 92
Medical use of combinations of non-natural semaphorins 3 and antimetabolites 89
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 88
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 83
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 82
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 81
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 80
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 78
Semaphorins and tumor angiogenesis 77
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. 77
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer 74
Class 3 semaphorin in angiogenesis and lymphangiogenesis 73
In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. 70
A novel population of neuropilin-1-expressing mononuclear cells (NEMs) contributes to tumor vessel stabilization and normalization 70
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 70
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 69
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 68
Increased Expression of {alpha}6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane 67
Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer 67
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer 66
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 65
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 65
Modeling the early stages of vascular network assembly. 63
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 62
Zoledronic acid inhibit angiogenesis and impairs tumorigenesis in a mouse model of cervical carcinogenesis 62
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy 62
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 62
Percolation, morphogenesis, and burgers dynamics in blood vessels formation. 61
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 60
Tumor necrosis factor-a regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. 60
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 59
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis 58
IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells. 57
Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1. 54
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 54
Squalenic nanoparticles with active targeting: in vivo results 53
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers 53
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner 53
Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA. 52
Targeted nanoparticles for pancreatic cancer. 51
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 51
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma 50
Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. 50
Targeted nanoparticles for pancreatic cancer. 49
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 49
Lymphatic zip codes in premalignant lesions and tumors 48
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. 48
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition 47
Nanoparticles targeting pancreatic tumor. 45
Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. 43
New human dihydroorotate dehydrogenase inhibitors able to restore myeloid differentiation in AML 39
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 38
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth 35
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front 31
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability 28
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 21
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression 19
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 18
PlexinB1 deficiency in the microenvironment inhibits tumor growth and metastatic dissemination in mouse models of triple negative breast cancer 18
Breast cancers as ecosystems: a metabolic perspective 14
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 13
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 9
PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination 9
Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer 8
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 8
Totale 10.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.687
article - articoli 0
book - libri 0
conference - conferenze 8.102
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.051 0 0 0 0 107 221 145 117 146 132 104 79
2020/20211.495 95 81 76 97 183 117 124 74 156 148 152 192
2021/20221.628 118 105 102 124 98 115 96 103 90 132 311 234
2022/20231.845 159 170 64 163 161 403 163 121 175 70 120 76
2023/20241.255 123 176 94 115 99 92 87 95 27 88 109 150
2024/2025648 75 147 173 214 39 0 0 0 0 0 0 0
Totale 10.664